GH Research (GHRS) Interest Expenses (2021 - 2025)
GH Research's (GHRS) quarterly Interest Expenses came in at -$179000.0 in Q4 2025, little changed year-on-year from -$179000.0 in Q4 2024, and down 752.38% quarter-over-quarter from -$21000.0 in Q3 2025.
GH Research (GHRS) Interest Expenses (2021 - 2025) Analysis & Trends
GH Research's Interest Expenses history runs 5 years deep, the most recent figure standing at -$179000.0 for Q4 2025.
- On a quarterly basis, Interest Expenses changed 0.0% year-over-year to -$179000.0 in Q4 2025; TTM through Dec 2025 was -$552000.0, a 23.01% increase from a year earlier, with the FY2025 full-year figure at -$639000.0, up 11.62% from the prior year.
- Interest Expenses declined to -$179000.0 in Q4 2025 per GHRS's latest filing, from -$21000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $1.1 million in Q4 2023 and bottomed at -$246000.0 in Q1 2023.
- The 5-year median for Interest Expenses is -$178000.0 (2024), against an average of -$45812.5.
- Across the five-year window, Interest Expenses soared 4963.64% in 2023 and tumbled 116.07% in 2024, its largest moves.
- Year by year, Interest Expenses stood at $18000.0 in 2021, then grew by 22.22% to $22000.0 in 2022, then surged by 4963.64% to $1.1 million in 2023, then tumbled by 116.07% to -$179000.0 in 2024, then changed by 0.0% to -$179000.0 in 2025.
- Per Business Quant, the three latest GHRS Interest Expenses figures stand at -$179000.0 (Q4 2025), -$21000.0 (Q3 2025), and -$174000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | GH Research | 1.69 Bn | 1.69 Bn | - | -179,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -179,000.00 |
| Dec 31, 2025 | -179,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | -174,000.00 |
| Jun 30, 2025 | -174,000.00 |
| Mar 31, 2025 | -178,000.00 |
| Mar 31, 2025 | -178,000.00 |
| Dec 31, 2024 | -179,000.00 |
| Dec 31, 2024 | -179,000.00 |
| Sep 30, 2024 | -181,000.00 |
| Sep 30, 2024 | -181,000.00 |
| Jun 30, 2024 | -178,000.00 |
| Jun 30, 2024 | -178,000.00 |
| Mar 31, 2024 | -179,000.00 |
| Mar 31, 2024 | -179,000.00 |
| Dec 31, 2023 | 1.11 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | -184,000.00 |
| Sep 30, 2023 | -184,000.00 |